Table 3– Multiple linear regression model describing predictors of sputum neutrophil percentages in all subjects with asthma
Unadjusted modelFinal model (R2=0.108, p=0.004)
β-coefficient (95% CI)p-valueβ-coefficient (95% CI)p-value
Age yrs0.395 (0.085–0.704)0.0130.330 (0.022–0.639)0.036
Sex0.108 (-9.486–9.702)0.982
BMI kg·m−20.937 (0.238–1.635)0.0090.801 (0.102–1.499)0.025
Total SFA mg·L−10.017 (-0.002–0.036)0.075
Total MUFA mg·L−10.016 (-0.001–−0.032)0.062
Total PUFA mg·L−10.003 (-0.014–0.019)0.760
ICS dose# μg·day−10.003 (-0.002–0.009)0.235
Use of ICS treatment yes/no4.831 (-4.515–14.177)0.308
  • BMI: body mass index; SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; ICS: inhaled corticosteroid. #: beclomethasone equivalents.